Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · December 18, 2024

Infliximab Plus Azathioprine vs Azathioprine Alone in Patients With Acute Severe Ulcerative Colitis Responsive to IV Steroids

Gut

 

Additional Info

Gut
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
Gut 2024 Nov 25;[EPub Ahead of Print], A Amiot, P Seksik, A Meyer, C Stefanescu, P Wils, R Altwegg, L Vuitton, L Plastaras, A Nicolau, B Pereira, N Duveau, D Laharie, B Mboup, M Boualit, M Allez, S Rajca, E Chanteloup, G Bouguen, T Bazin, F Goutorbe, N Richard, D Moussata, E Vicaut, L Peyrin-Biroulet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading